Taro Pharmaceutical Industries shares owned by Us Bancorp
Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Us Bancorp
from 13F filings
Historical chart of Us Bancorp investment in Taro Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Taro Pharmaceutical Industries held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taro Pharmaceutical Industries by Us Bancorp
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.6k | 230 | 41.78 |
| 2023-09-30 | $48k | 1.3k | 37.71 |
| 2023-06-30 | $316k | 8.3k | 37.93 |
| 2023-03-31 | $212k | 8.7k | 24.32 |
| 2022-12-31 | $254k | 8.8k | 29.04 |
| 2022-09-30 | $295k | 9.8k | 30.06 |
| 2022-06-30 | $364k | 10k | 36.11 |
| 2022-03-31 | $454k | 11k | 43.24 |
| 2021-12-31 | $503k | 10k | 50.05 |
| 2021-09-30 | $681k | 11k | 63.70 |
| 2021-06-30 | $802k | 11k | 71.93 |
| 2021-03-31 | $844k | 11k | 73.71 |
| 2020-12-31 | $839k | 11k | 73.38 |
| 2020-09-30 | $673k | 12k | 54.89 |
| 2020-06-30 | $819k | 12k | 66.55 |
| 2020-03-31 | $816k | 13k | 61.19 |
| 2019-12-31 | $1.3M | 14k | 87.93 |
| 2019-09-30 | $1.1M | 15k | 75.42 |
| 2019-06-30 | $1.2M | 14k | 85.31 |
| 2019-03-31 | $979k | 9.1k | 108.03 |
| 2018-12-31 | $7.0k | 81 | 86.42 |
| 2018-09-30 | $5.0k | 48 | 104.17 |
| 2018-06-30 | $13k | 114 | 114.04 |
| 2018-03-31 | $16k | 164 | 97.56 |
| 2017-12-31 | $102k | 979 | 104.61 |
| 2017-09-30 | $162k | 1.4k | 112.93 |
| 2017-06-30 | $334k | 3.0k | 111.97 |
| 2017-03-31 | $233k | 2.0k | 116.52 |
| 2016-12-31 | $123k | 1.2k | 105.08 |
| 2016-09-30 | $605k | 5.5k | 110.62 |
| 2016-06-30 | $824k | 5.7k | 145.61 |
| 2016-03-31 | $801k | 5.6k | 143.29 |
| 2015-12-31 | $850k | 5.5k | 154.52 |
| 2015-09-30 | $1.2M | 8.4k | 142.95 |
| 2015-06-30 | $1.1M | 7.6k | 143.75 |
| 2015-03-31 | $1.1M | 7.6k | 141.09 |
Top funds holding Taro Pharmaceutical Industries
View all funds holding Taro Pharmaceutical Industries